Professional Documents
Culture Documents
preparation
By,
uthara menon
Ist MDS
contents
INTRODUCTION
INTRODUCTION
ORAL MUCOSA:
STRUCTURE AND
PERMEABILITY
FEATURES
Oral mucosa-total surface area-200cm
NON KERATINIZED
EPITHELIUM
KERATINIZED
EPITHELIUM
(Oral Surg
Oralmucosa
Pathol Oral Radiol
The epithelium
of Oral
theMed
oral
is 2012;114:e25-
Transport of substances
1.PASSIVE DIFFUSION,
the intracellular (or transcellular) pathway,and
the intercellular (or paracellular) pathway
2.CARRIER-MEDIATED ACTIVE TRANSPORT,
OR
3.ENDOCYTOSIS
drug interactions
(Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:e25-
drawbacks
1.Rapid drug loss from the site of absorption by
salivary scavenging and mechanical stress;
2. The non-uniform distribution of drugs in
saliva on
release from delivery systems, which implies
that
certain areas of the oral cavity might not
receive
therapeutic levels of drugs;
3. Poor patient compliance because of an
unpleasant
(Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:e25-
Chemical penetration
enhancers
Reducing the viscosity and/or elasticity of the
mucus layer, or by transiently altering the lipid
bilayer
membrane,
or
overcoming
the
enzymatic
barrier,
or
increasing
the
thermodynamic activity of the permeant.
CHELATORS
(e.g. sodium EDTA or salicylates),
SURFACTANTS (e.g. sodium dodecyl sulfate),
BILE SALTS
(e.g. sodium deoxycholate,
sodium glycocholate),
FATTY ACIDS (e.g. oleic acid, capric acid and
lauric acid) and
Nicolazzo, J.A. et al. (2005) Buccal
penetration
enhancers: how
do they
NONSURFACTANTS
(e.g.
ciclodextrins
and
really work? J. Control. Release 105, 115
Mechanical penetration
enhancers
By removing the outermost layers from
epithelium to decrease the barrier thickness, or
electrically,
for example, by application of electric fields or
by SONOPHORESIS.
SONOPHORESIS. :
Reducing, temporarily, the density of lipids in
the intercellular domain of the membrane.
a combination of micromechanical, thermic and
cavitation effects that effectively open up the
intracellular pathways, allowing substances to
Drug Discovery Today Volume 13, Numbers 5/6 March
Mucoadhesive dosage
forms
Mucoadhesion
phenomenon
Dosage forms
Dosage forms can be classified into the following
categories:
MONOLITHIC (or matrix) type,
The drug is uniformly dispersed or dissolved in
the polymer matrix and drug release is effected
by diffusion through the polymer network .
and
RESERVOIR (or membrane-controlled) type
A drug reservoir is entrapped between an
impermeable backing layer and a polymeric
membrane that controls the rate of drug
release. (Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:e25-
desirable attributes
high drug-loading capacity,
nonirritancy of the tissue,
good mucoadhesion,
sufficiently reduced dimension,
and physical flexibility to be acceptable (in
termsof comfort) to the patient,
tasteless, and
sustained drug delivery
Adhesive tablets
Buccal tablets are small, flat, and oval with an
approximate diameter of 5 to 8 mm and
thickness of about 2 mm.
In the presence of saliva, they adhere to the
mucosal surface until dissolution and/or drug
release is complete.
Adhesive buccal tablets can be applied to
different sites in the oral cavity, including the
palate and the mucosa of the cheeks.
Mucoadhesive tablets containing chlorhexidine
were designed to swell and form a gel, adhering
to the
mucosa
and controlling
drug
release
Mizrahi
B, Domb
AJ. Mucoadhesive
polymers for the
delivery
of drugs
to the
oral
cavity.
Recent
Drug Deliv Formul 2008;2:108-19
into
the
oralPatcavity
advantages
high flexibility, thus facilitating a long
residence/retention time,(useful in the treatment
of mild or severe diffuse oral diseases)
Adhesive semisolid
systems (gels,
ointments)
ADVANTAGE :
DISADVANTAGE:
The residence time of gels is small because
body fluids, such as saliva, will quickly wash
them away from the site of action.
Narrow therapeutic window.
APPLICATION:
periodontitis,
recurrent aphthous stomatitis,
traumatic ulcers,
radiation- or chemotherapy- induced oral
mucositis,
chronic immunologically mediated oral
lesions,
hyposalivation, and,
recently, for the healing of wounds
conclusion
The relative impermeability of the oral cavity,
other variables pertaining to the oral
environment (e.g., eating and the effects of
saliva), and acceptability by the patient must
be considered in developing new dosage
forms. The development of new formulations
for topical drug delivery within the oral cavity
is a research field that should be intensively
investigated, considering the high prevalence
of oral mucosal lesions and periodontal
Thank
you